Dopamine Abundance Uncouples Neurodegeneration And Lifespan In A C. Elegans Model Of Parkinson’S Disease
Parkinson’s disease is characterized by the loss of brain cells that produce dopamine and the buildup of a protein called alpha-synuclein. Scientists have observed in a worm model of this disease that while the loss of these brain cells increases with age, it doesn’t necessarily shorten the worm’s life. This study explored how the amount of dopamine affects both the damage to these brain cells and the overall lifespan of these worms.
The research revealed that having more dopamine actually made the brain cell damage worse, whereas reducing dopamine levels helped protect the brain cells. A crucial discovery was identifying a specific interaction between dopamine and alpha-synuclein that acts as a central trigger. This interaction leads to two distinct outcomes: localized damage to dopamine-producing brain cells due to stress from unstable molecules, and a broader, body-wide response that helps the organism cope with stress and, surprisingly, extends its lifespan. These findings suggest that future treatments could focus on boosting the body’s general stress response, for example by modulating a cellular recycling process called autophagy, to potentially extend lifespan without increasing the specific damage to brain cells.
Source: link to paper